Ensysce Biosciences (ENSC) Accounts Payables (2017 - 2025)
Ensysce Biosciences' Accounts Payables was $3.27 million in Q4 2025, up 140.8% from $1.36 million a year earlier and up 605.0% from the prior quarter.
Powered by 
Analysis
Ensysce Biosciences (ENSC) Accounts Payables (2017 - 2025) Analysis & Trends
From Q4 2017 onward, Ensysce Biosciences has reported Accounts Payables for 33 quarters.
- Accounts Payables shows a five-year compound annual growth rate of 13.6% (FY2020 to FY2025).
- In earlier years, Accounts Payables was $1.36 million in FY2024 (-29.9%), $1.94 million in FY2023 (-34.2%), $2.94 million in FY2022 (+877.7%) and $301,104 in FY2021 (-82.5%).
- The Q4 2025 figure marks the highest quarterly Accounts Payables since Q1 2020.
- Compared with a year earlier, Accounts Payables was higher in three of the last eight quarters, with growth averaging 15.9%.
- The best year-over-year quarter for Accounts Payables over five years was Q4 2022 (growth of 877.7%); the worst was Q1 2021 (a decline of 90.9%).
- Per Business Quant data, ENSC's Accounts Payables in the three quarters before Q4 2025 was $463,458 (Q3 2025), $1.04 million (Q2 2025) and $615,295 (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,130.22 Bn | 1,098.81 Bn | 19.71 Bn | 6.11 Bn |
| 2 | Johnson & Johnson | 613.62 Bn | 532.15 Bn | 17.26 Bn | 9.22 Bn |
| 3 | AbbVie | 501.46 Bn | 474.57 Bn | 12.70 Bn | 33.30 Bn |
| 4 | Merck | 366.84 Bn | 321.22 Bn | 12.21 Bn | 3.83 Bn |
| 5 | Novartis Ag | 297.85 Bn | 261.84 Bn | 11.24 Bn | 4.26 Bn |
| 6 | Astrazeneca | 261.66 Bn | 235.34 Bn | 12.86 Bn | 22.89 Bn |
| 7 | Amgen | 235.39 Bn | 190.79 Bn | 7.24 Bn | 2.87 Bn |
| 8 | Gilead Sciences | 190.66 Bn | 164.86 Bn | 6.22 Bn | 674.00 Mn |
| 9 | Pfizer | 169.57 Bn | 116.22 Bn | 10.94 Bn | 4.58 Bn |
| 10 | Ensysce Biosciences | 1.27 Mn | -9.98 Mn | - | 3.27 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 3.27 Mn |
| Sep 30, 2025 | 463,458.00 |
| Jun 30, 2025 | 1.04 Mn |
| Mar 31, 2025 | 615,295.00 |
| Dec 31, 2024 | 1.36 Mn |
| Sep 30, 2024 | 1.97 Mn |
| Jun 30, 2024 | 481,971.00 |
| Mar 31, 2024 | 981,720.00 |
| Dec 31, 2023 | 1.94 Mn |
| Sep 30, 2023 | 916,416.00 |
| Jun 30, 2023 | 1.27 Mn |
| Mar 31, 2023 | 1.60 Mn |
| Dec 31, 2022 | 2.94 Mn |
| Sep 30, 2022 | 1.29 Mn |
| Jun 30, 2022 | 3.05 Mn |
| Mar 31, 2022 | 959,630.00 |
| Dec 31, 2021 | 301,104.00 |
| Sep 30, 2021 | 471,858.00 |
| Jun 30, 2021 | 3.14 Mn |
| Mar 31, 2021 | 319,180.00 |
API Access
Ensysce Biosciences Accounts Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accounts-payables&ticker=ENSC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accounts-payables", "ticker": "ENSC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accounts-payables&ticker=ENSC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();